0
0
1/9/23 at 2:03pm
Organization
MedPage Today
Author
Ingrid Hein
27 words
0
Comments
Phase II results move field closer to twice-yearly dosing, although ART options remain a hurdle
You are the first to view
https://www.medpagetoday.com/hivaids/hivaids/102561
Create an account
or login to join the discussion